122310.KQ Genoray Co. Ltd

Healthcare Oil, Gas & Consumable Fuels KOSDAQ
3,010 KRW
Close of Nov 1, 2026
2,995 5,014
Market cap
KRW 38.3B
P/E
15.1x
P/B
0.47x
ROE
0.5%
Dividend yield
5.85%
Fundamental score
2.7/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 122310.KQ undervalued?

Graham number
Price3,010
Graham value5,369
Discount43.9%

122310.KQ trades 43.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Genoray Co. Ltd fundamental analysis

13 of 22 checks passed

ROE 0/2

Low return on equity (0.5%), below 10%.

ROA 0/1

Return on assets (0.3%) is below the industry median (1.4%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (142.0%) is above the 5-year average (-39.1% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (142.0%) is above the industry median (1.8%).

Revenue Growth 1/2

Revenue grew 9.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (4.1%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 0/1

EBIT is 1.4x against interest expense, below 5x.

PE vs Market 0/1

PE (15.1x) is above the market median (11.3x).

PE vs Industry 0/1

PE (15.1x) is above the industry median (11.4x).

PBV 1/1

Price to book (0.5x) is below the industry median (0.9x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 7.1, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 2/2

Dividend yield (5.9%) is in the top 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 0/1

Payout ratio is 296.1%, above 90% of earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Genoray Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Genoray Co. Ltd

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It provides C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

Full company profile